Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 26, 2022, to announce its financial results for the fiscal quarter ended October 1, 2022. The press release containing these results is furnished as an exhibit. This filing provides investors with an update on the company's performance during the third quarter of fiscal year 2022. While the 8-K itself does not contain detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for comprehensive information. Investors should refer to this press release for key metrics such as revenue, earnings per share (EPS), and any forward-looking guidance provided by the company. This is a standard practice for 8-K filings related to earnings announcements, allowing for immediate dissemination of financial performance data.
Key Highlights
- 1Thermo Fisher Scientific announced its Q3 2022 financial results on October 26, 2022.
- 2The detailed financial results are available in the press release furnished as Exhibit 99.1.
- 3This 8-K filing serves as the official notification of the company's quarterly performance.
- 4Investors are directed to the press release for specific financial data and operational updates.
- 5The filing does not include the financial results directly but references the external exhibit for them.
- 6This event date was October 25, 2022, with the filing occurring on October 25, 2022.